Lonza

📍 Basel, Switzerland🗓 Founded 1897👥 17,942 employees💰 Last funded Feb 2020
Pharmaceutical Manufacturing🌐 lonza.com
Website LinkedIn
Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1897
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Brazil
1
Frequently asked questions
Who invested in Lonza?
Lonza has 1 investors on record on gritt.io.
When did Lonza last raise funding?
The most recent investment in Lonza recorded on gritt.io was in February 2020.
When was Lonza founded?
Lonza was founded in 1897.
What industry is Lonza in?
Lonza operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Lonza based?
Lonza is headquartered in Basel, Switzerland.